THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA

Gonullu, E.Kalyoncu, U.Yagiz, B.Ates, A.Kucuksahin, O.Bilge, S. YasarKanitez, N. A.2024-09-182024-09-1820220003-49671468-2060https://doi.org/10.1136/annrheumdis-2022-eular.2721https://hdl.handle.net/20.500.12483/13044EULAR European Congress of Rheumatology (EULAR) -- JUN 01-04, 2022 -- Copenhagen, DENMARK[Abstract Not Available]eninfo:eu-repo/semantics/openAccessTHE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATAConference Object811304130410.1136/annrheumdis-2022-eular.2721WOS:000850279005213Q1